CPT codes

53861 CPT codes with hospital pricing data in the network.

• CPT 545U — Acetylcholine receptor (AChR), antibody identification by immunofluorescence, using live cells, reported as positive or negative (1 hospital, — samples)
• CPT 546 — ANESTH LUNG CHEST WALL SURG (12 hospitals, — samples)
• CPT 546T — RF SPECTRSC NTRAOP MRGN ASMT (12 hospitals, — samples)
• CPT 546U — Low-density lipoprotein receptor-related protein 4 (LRP4), antibody identification by immunofluorescence, using live cells, reported as positive or negative (1 hospital, — samples)
• CPT 547T — B1 MATRL QUAL TST MCRIND TIB (12 hospitals, — samples)
• CPT 547U — Neurofilament light chain (NfL), chemiluminescent enzyme immunoassay, plasma, quantitative (1 hospital, — samples)
• CPT 548U — Glial fibrillary acidic protein (GFAP), chemiluminescent enzyme immunoassay, using plasma (1 hospital, — samples)
• CPT 549U — Oncology (urothelial), DNA, quantitative methylated real-time PCR of TRNA-Cys, SIM2, and NKX1-1, using urine, diagnostic algorithm reported as a probability index for bladder cancer and/or upper tract urothelial carcinoma (UTUC) (1 hospital, — samples)
• CPT 54T — BONE SRGRY CMPTR FLUOR IMAGE (12 hospitals, — samples)
• CPT 54U — RX MNTR 14+ DRUGS & SBSTS (12 hospitals, — samples)
• CPT 550U — Oncology (prostate), enzyme-linked immunosorbent assays (ELISA) for total prostate-specific antigen (PSA) and free PSA, serum, combined with age, previous negative prostate biopsy status, digital rectal examination findings, prostate volume, and image and (1 hospital, — samples)
• CPT 551U — Tau, phosphorylated, pTau217, by single-molecule array (ultrasensitive digital protein detection), using plasma (1 hospital, — samples)
• CPT 552T — LOW-LEVEL LASER THERAPY (12 hospitals, — samples)
• CPT 552U — Reproductive medicine (preimplantation genetic assessment), analysis for known genetic disorders from trophectoderm biopsy, linkage analysis of disease-causing locus, and when possible, targeted mutation analysis for known familial variant, reported as lo (1 hospital, — samples)
• CPT 553T — PERQ TCAT ILIAC ANAST IMPLT (12 hospitals, — samples)
• CPT 553U — Reproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using DNA genomic sequence analysis from embryonic trophectoderm for structural rearrangements, aneuploidy, and a mitochondrial DNA score, results reported as normal/ba (1 hospital, — samples)
• CPT 554T — B1 STR & FX RSK ANALYSIS (12 hospitals, — samples)
• CPT 554U — Reproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using DNA genomic sequence analysis from trophectoderm biopsy for aneuploidy, ploidy, a mitochondrial DNA score, and embryo quality control, results reported as normal (1 hospital, — samples)
• CPT 555T — B1 STR&FX RSK TRANSMIS DATA (12 hospitals, — samples)
• CPT 555U — Reproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using DNA genomic sequence analysis from embryonic trophectoderm for structural rearrangements, aneuploidy, ploidy, a mitochondrial DNA score, and embryo quality contro (1 hospital, — samples)
• CPT 556T — B1 STR & FX RSK ASSESSMENT (12 hospitals, — samples)
• CPT 556U — Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific DNA and RNA by real-time PCR, 12 targets, nasopharyngeal or oropharyngeal swab, including multiplex reverse transcription for RNA targets, each analyte reported as dete (1 hospital, — samples)
• CPT 557T — B1 STR & FX RSK I&R (12 hospitals, — samples)
• CPT 557U — Infectious disease (bacterial vaginosis and vaginitis), real-time amplification of DNA markers for Atopobium vaginae, Gardnerella vaginalis, Megasphaera types 1 and 2, bacterial vaginosis associated bacteria-2 and -3 (BVAB-2, BVAB-3), Mobiluncus species, (1 hospital, — samples)
• CPT 55867 — LAPAROSCOPY, SURGICAL PROSTATECTOMY, SIMPLE SUBTOTAL (INCLUDING CONTROL OF POSTOPERATIVE BLEEDING, VASECTOMY, MEATOTOMY, URETHRAL CALIBRATION AND/OR DILATION, AND INTERNAL URETHROTOMY), INCLUDES ROBOTIC ASSISTANCE, WHEN PERFORMED (3 hospitals, — samples)
• CPT 55881 — PR ABLATION TRANSURETHRAL PRST8 TISSUE W/THERMAL US (1 hospital, — samples)
• CPT 55882 — ABLATION OF PROSTATE TISSUE, TRANSURETHRAL, USING THERMAL ULTRASOUND, INCLUDING MAGNETIC RESONANCE IMAGING GUIDANCE FOR, AND MONITORING OF, TISSUE ABLATION; WITH INSERTION OF TRANSURETHRAL ULTRASOUND TRANSDUCER FOR DELIVERY OF THERMAL ULTRASOUND, INCLUDING SUPRAPUBIC TUBE PLACEMENT AND PLACEMENT OF AN ENDORECTAL COOLING DEVICE, WHEN PERFORMED (1 hospital, — samples)
• CPT 558T — CT SCAN F/BIOMCHN CT ALYS (12 hospitals, — samples)
• CPT 558U — Oncology (colorectal), quantitative enzyme-linked immunosorbent assay (ELISA) for secreted colorectal cancer protein marker (BF7 antigen), using serum, result reported as indicative of response/no response to therapy or disease progression/regression (1 hospital, — samples)
• CPT 559T — ANTMC MDL 3D PRINT 1ST CMPNT (12 hospitals, — samples)
• CPT 559U — Oncology (breast), quantitative enzyme-linked immunosorbent assay (ELISA) for secreted breast cancer protein marker (BF9 antigen), serum, result reported as indicative of response/no response to therapy or disease progression/regression (1 hospital, — samples)
• CPT 55T — BONE SRGRY CMPTR CT/MRI IMAG (12 hospitals, — samples)
• CPT 55U — CARD HRT TRNSPL 96 DNA SEQ (12 hospitals, — samples)
• CPT 560 — ANESTH HEART SURG W/O PUMP (12 hospitals, — samples)
• CPT 560T — ANTMC MDL 3D PRINT EA ADDL (12 hospitals, — samples)
• CPT 560U — Oncology (minimal residual disease [MRD]), genomic sequence analysis, cell-free DNA, whole blood and tumor tissue, baseline assessment for design and construction of a personalized variant panel to evaluate current MRD and for comparison to subsequent MRD (1 hospital, — samples)
• CPT 561 — ANESTH HEART SURG <1 YR (12 hospitals, — samples)
• CPT 561T — ANTMC GUIDE 3D PRINT 1ST GD (12 hospitals, — samples)
• CPT 561U — Oncology (minimal residual disease [MRD]), genomic sequence analysis, cell-free DNA, whole blood, subsequent assessment with comparison to initial assessment to evaluate for MRD (1 hospital, — samples)
• CPT 562 — ANESTH HRT SURG W/PMP AGE 1+ (12 hospitals, — samples)
• CPT 562T — ANTMC GUIDE 3D PRINT EA ADDL (12 hospitals, — samples)
• CPT 562U — Oncology (solid tumor), targeted genomic sequence analysis, 33 genes, detection of single-nucleotide variants (SNVs), insertions and deletions, copy-number amplifications, and translocations in human genomic circulating cell-free DNA, plasma, reported as (1 hospital, — samples)
• CPT 563T — EVAC MEIBOMIAN GLND HEAT BI (12 hospitals, — samples)
• CPT 563U — Infectious disease (bacterial and/or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 11 viral targets and 4 bacterial targets, qualitative RT-PCR, upper respiratory specimen, each pathogen reported as positive or negative (1 hospital, — samples)
• CPT 564T — ONC CHEMO RX CYTOTOX CSC 14 (12 hospitals, — samples)
• CPT 564U — Infectious disease (bacterial and/or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 10 viral targets and 4 bacterial targets, qualitative RT-PCR, upper respiratory specimen, each pathogen reported as positive or negative (1 hospital, — samples)
• CPT 565T — AUTOL CELL IMPLT ADPS HRVG (12 hospitals, — samples)
• CPT 565U — Oncology (hepatocellular carcinoma), next-generation sequencing methylation pattern assay to detect 6626 epigenetic alterations, cell-free DNA, plasma, algorithm reported as cancer signal detected or not detected (1 hospital, — samples)
• CPT 566T — AUTOL CELL IMPLT ADPS NJX (12 hospitals, — samples)
• CPT 566U — Oncology (lung), qPCR-based analysis of 13 differentially methylated regions (CCDC181, HOXA7, LRRC8A, MARCHF11, MIR129-2, NCOR2, PANTR1, PRKCB, SLC9A3, TBR1_2, TRAP1, VWC2, ZNF781), pleural fluid, algorithm reported as a qualitative result (1 hospital, — samples)